Yahoo
OTC Markets OTCPK - Delayed Quote USD

Igene Biotechnology, Inc. (IGNE)

0.0000 0.0000 (0.00%)
As of November 5 at 4:00:00 PM EST. Market Open.
Chart Range Bar
Loading chart for IGNE
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 50,560
  • Avg. Volume 0
  • Market Cap (intraday) 15,654
  • Beta (5Y Monthly) -29.94
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.

www.igene.com

18

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IGNE
0.00%
S&P 500 (^GSPC)
8.29%

1-Year Return

IGNE
0.00%
S&P 500 (^GSPC)
10.31%

3-Year Return

IGNE
0.00%
S&P 500 (^GSPC)
69.79%

5-Year Return

IGNE
90.00%
S&P 500 (^GSPC)
57.81%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -8.21%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.8k

  • Net Income Avi to Common (ttm)

    -2.37M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    269.29k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -442.78k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: